Pacific Biosciences has a deal to sell shares and could raise up to $100 million.

Nov 10, 2026, 4:31 PM ETNew sharesRead the original at SEC EDGAR

Bad for PACB

PACB can raise up to $100 million, giving it access to cash, but selling new shares would make each current owner's slice smaller. No sales are required, so the risk is not certain, but the possible increase in shares makes this unfavorable.

PACB · Pacific Biosciences of California, Inc.

AI read · Bad for PACB

The AI's read

The program gives PACB a way to bring in cash if it needs it. But selling shares gives current owners a smaller part of the company. PACB does not have to sell any shares, so that risk is not certain. Still, the possible increase in shares makes this unfavorable.

Get alerts for PACB

Follow Pacific Biosciences of California, Inc. (PACB) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for PACB

Free on the App Store and Google Play, or on the web.